Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
87 studies found for:    Lupus AND (woman OR women OR female)
Show Display Options
RSS Create an RSS feed from your search for:
Lupus AND (woman OR women OR female)
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Statins and Lupus: Effects of Statins on Clinical Lupus Parameters, Serological Markers and Toll-like Receptors
Condition: Systemic Lupus Erythematosus
Intervention: Drug: atorvastatin
2 Unknown  Estrogen and Gender Biased Autoimmunity
Condition: Systemic Lupus Erythematosus
Intervention: Other: Peripheral lab draws
3 Completed GL701 (Prestara™) in Women With Systemic Lupus Erythematosus Receiving Treatment With Glucocorticoids
Condition: Systemic Lupus Erythematosus
Intervention: Drug: Prasterone (GL701)
4 Completed Insulin Resistance and Atherosclerosis in Women With Lupus
Conditions: Systemic Lupus Erythematosus;   Insulin Resistance;   Atherosclerosis
Intervention:
5 Completed Effect of Pioglitazone on Endothelial Function in Premenopausal Women With Uncomplicated Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Interventions: Drug: pioglitazone;   Drug: placebo
6 Unknown  To Assess Prevention of Bone Loss in Women With Lupus Receiving Treatment With Glucocorticoids
Condition: Lupus
Intervention: Drug: Prasterone (GL701)
7 Recruiting A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ABT-199 in Female Patients With Systemic Lupus Erythematosus (SLE)
Condition: Lupus Erythematosus
Interventions: Drug: ABT-199;   Other: Placebo
8 Terminated
Has Results
Effect of Simvastatin on Endothelial Function in Premenopausal Women With Systemic Lupus Erythematosus (0733-271)(TERMINATED)
Condition: Systemic Lupus Erythematosus
Interventions: Drug: simvastatin;   Drug: Comparator: Placebo
9 Completed Randomized Study of Oral Contraceptives or Hormone Replacement Therapy in Women With Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Interventions: Drug: estradiol;   Drug: ethinyl estradiol;   Drug: medroxyprogesterone;   Drug: norethindrone
10 Completed Immunogenicity and Safety of HPV Vaccine Gardasil in Young Women
Condition: Systemic Lupus Erythematosus
Intervention: Biological: Gardasil
11 Completed Psychoeducational Approach to Improve Health in Lupus
Condition: Systemic Lupus Erythematosus
Interventions: Procedure: Counseling intervention;   Device: Informational film
12 Completed Effect of Hormone Replacement Therapy on Lupus Activity
Condition: Systemic Lupus Erythematosus
Intervention: Drug: Conjugated equine estrogens 0.625 mg/d + MPA 5 mg/d/10d
13 Completed Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE)
Conditions: Systemic Lupus Erythematosus;   Lupus
Interventions: Drug: pravastatin;   Drug: aspirin;   Drug: ramipril;   Drug: Vitamins: B6, B12, and folate;   Behavioral: heart health educational program
14 Completed Safety of Estrogens in Lupus: Birth Control Pills
Condition: Systemic Lupus Erythematosus
Intervention: Drug: Ortho-Novum 777
15 Unknown  Dehydroepiandrosterone (DHEA) in Systemic Lupus Erythematosus (SLE) for Coronary Artery Disease (CAD) Prevention
Condition: Systemic Lupus Erythematosus
Intervention: Drug: Dehydroepiandrosterone (DHEA)
16 Recruiting Duke Autoimmunity in Pregnancy Registry
Conditions: Pregnancy;   Systemic Lupus Erythematosus;   Cutaneous Lupus;   Rheumatoid Arthritis;   Sjogren's Syndrome;   Scleroderma
Intervention:
17 Recruiting Belimumab (BENLYSTA®) Pregnancy Registry
Condition: Systemic Lupus Erythematosus
Intervention: Drug: belimumab
18 Completed Epidemiologic Study of Reproductive Outcome in Women With Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention:
19 Completed Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Active Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Drug: dehydroepiandrosterone
20 Completed Phase II/III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Mild to Moderate Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Drug: dehydroepiandrosterone

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years